 |
Mack Roach III, MD
Recent Publications |
Publications – 2008 |
 |
Chan, L.W., P. Xia, A.R. Gottschalk,
M. Akazawa, M. Scala, B. Pickett, I.-C. Hsu, J. Speight,
and M. Roach, Proposed Rectal Dose for
Patients Undergoing Definitive Whole Pelvic Radiotherapy
for Clinically Localized Prostate Cancer. International Journal
of Radiation Oncology, Biology, Physics, 2008. |
|
D'Ambrosio, D.J., A. Pollack, E.E. Harris,
R.A. Price, Jr., L.J. Verhey, M. Roach, 3rd, D.J. Demanes,
M.L. Steinberg, L. Potters, P.E. Wallner, and A. Konski,
Assessment of external beam radiation technology for dose
escalation and normal tissue protection in the treatment
of prostate cancer. Int J Radiat Oncol Biol Phys, 2008. 70(3):
p. 671-7. |
|
Lometti, M.W., D. Thurston, M. Aubin, A. Bock, L. Verhey,
J.M. Lockhart, R. Bland, J. Pouliot, and M. Roach, 3rd, Are
lateral electronic portal images adequate for accurate on-line
daily targeting of the prostate? Results of a prospective
study. Med Dosim, 2008. 33(1): p. 22-9. |
|
McKenna, D.A., F.V. Coakley, A.C. Westphalen, S. Zhao,
Y. Lu, E.M. Webb, B. Pickett, M. Roach, 3rd, and J. Kurhanewicz,
Prostate Cancer: Role of Pretreatment MR in Predicting Outcome
after External-Beam Radiation Therapy--Initial Experience.
Radiology, 2008. |
|
Roach, M., 3rd, K. Bae, J. Speight, H.B. Wolkov, P. Rubin,
R.J. Lee, C. Lawton, R. Valicenti, D. Grignon, and M.V. Pilepich,
Short-term neoadjuvant androgen deprivation therapy and external-beam
radiotherapy for locally advanced prostate cancer: long-term
results of RTOG 8610. J Clin Oncol, 2008. 26(4): p. 585-91. |
|
Roach, M., H. Chung, and J.L. Speight,
Intermediate-risk and Locally Advanced Prostate Cancer, in
Principles and Practice of Radiation Oncology, E. Halperin,
C. Perez, and L. Brady, Editors. 2008, Lippincott, Williams
and Wilkins. |
|
Shinohara, K. and M. Roach, 3rd, Technique for Implantation
of Fiducial Markers in the Prostate. Urology, 2008. 71(2):
p. 196-200. |
|
Taussky, D., K. Bae, J.P. Bahary, M. Roach, 3rd, C.A.
Lawton, W.U. Shipley, and H.M. Sandler, Does Timing of Androgen
Deprivation Influence Radiation-Induced Toxicity? A Secondary
Analysis of Radiation Therapy Oncology Group Protocol 9413.
Urology, 2008. |
| |
Publications – 2007 |
|
Bermudez, R.S., A. Izaguirre, and M. Roach,
3rd, State-of-the-art radiotherapy in the management of clinically
localized prostate carcinoma. Future Oncol, 2007. 3(1): p.
103-11. |
|
Frank, S.J., P.D. Grimm, J.E. Sylvester,
G.S. Merrick, B.J. Davis, A. Zietman, B.J. Moran, D.C. Beyer,
M. Roach, 3rd, D.H. Clarke, R.G. Stock, W. Robert Lee, J.M.
Michalski, K.E. Wallner, M. Hurwitz, L. Potters, D.A. Kuban,
B.R. Prestidge, R. Vera, S. Hathaway, and J.C. Blasko, Interstitial
implant alone or in combination with external beam radiation
therapy for intermediate-risk prostate cancer: a survey of
practice patterns in the United States. Brachytherapy, 2007.
6(1): p. 2-8. |
|
Lawton, C.A., M. Desilvio, M. Roach, 3rd,
V. Uhl, R. Kirsch, M. Seider, M. Rotman, C. Jones, S. Asbell,
R. Valicenti, S. Hahn, and C.R. Thomas, Jr., An Update of
the Phase III Trial Comparing Whole Pelvic to Prostate Only
Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression:
Updated Analysis of RTOG 94-13, with Emphasis on Unexpected
Hormone/Radiation Interactions. Int J Radiat Oncol Biol Phys,
2007. |
|
Lawton, C.A., M. DeSilvio, M. Roach, 3rd,
V. Uhl, R. Kirsch, M. Seider, M. Rotman, C. Jones, S. Asbell,
R. Valicenti, S. Hahn, and C.R. Thomas, Jr., An update of
the phase III trial comparing whole pelvic to prostate only
radiotherapy and neoadjuvant to adjuvant total androgen suppression:
updated analysis of RTOG 94-13, with emphasis on unexpected
hormone/radiation interactions. Int J Radiat Oncol Biol Phys,
2007. 69(3): p. 646-55. |
|
Lee, B., K. Shinohara, V. Weinberg, A.R.
Gottschalk, J. Pouliot, M. Roach, 3rd, and I.C. Hsu, Feasibility
of high-dose-rate brachytherapy salvage for local prostate
cancer recurrence after radiotherapy: the University of California-San
Francisco experience. Int J Radiat Oncol Biol Phys, 2007.
67(4): p. 1106-12. |
|
Litzenberg, D.W., T.R. Willoughby, J.M.
Balter, H.M. Sandler, J. Wei, P.A. Kupelian, A.A. Cunningham,
A. Bock, M. Aubin, M. Roach, 3rd, K. Shinohara, and J. Pouliot,
Positional Stability of Electromagnetic Transponders Used
for Prostate Localization and Continuous, Real-Time Tracking.
Int J Radiat Oncol Biol Phys, 2007. |
|
Ludlum, E., G. Mu, V. Weinberg, M. Roach, 3rd, L.J. Verhey,
and P. Xia, An algorithm for shifting MLC shapes to adjust
for daily prostate movement during concurrent treatment with
pelvic lymph nodes. Med Phys, 2007. 34(12): p. 4750-6. |
|
Meyer, J.L., S. Leibel, M. Roach, and S. Vijayakumar,
New technologies for the radiotherapy of prostate cancer.
A discussion of clinical treatment programs. Front Radiat
Ther Oncol, 2007. 40: p. 315-37. |
|
Mohler, J., R.J. Babaian, R.R. Bahnson, B. Boston, A.
D'Amico, J.A. Eastham, R.J. Hauke, R.P. Huben, P. Kantoff,
M. Kawachi, M. Kuettel, P.H. Lange, C. Logothetis, G. MacVicar,
A. Pollack, J.M. Pow-Sang, M. Roach, 3rd, H. Sandler, D.
Shrieve, S. Srinivas, P. Twardowski, D.A. Urban, and P.C.
Walsh, Prostate cancer. Clinical practice guidelines in oncology.
J Natl Compr Canc Netw, 2007. 5(7): p. 650-83. |
|
Roach, M., 3rd, Dose escalated external beam radiotherapy
versus neoadjuvant androgen deprivation therapy and conventional
dose external beam radiotherapy for clinically localized
prostate cancer: do we need both? Strahlenther Onkol, 2007.
183 Spec No 2: p. 26-8. |
|
Roach, M., 3rd, Editorial Comment on: High Provider Volume
is Associated with Lower Rate of Secondary Therapies after
Definitive Radiotherapy for Localized Prostate Cancer. Eur
Urol, 2007. |
|
Roach, M., 3rd, Regarding the influence of adjuvant suppression
therapy for prostate cancer on the frequency and timing of
fatal myocardial infarction: how real is the risk? J Clin
Oncol, 2007. 25(33): p. 5325-6; author reply 5326. |
|
Roach, M., 3rd, M. De Silvio, T. Rebbick,
D. Grignon, M. Rotman, H. Wolkov, B. Fisher, G. Hanks, W.U.
Shipley, A. Pollack, H. Sandler, and D. Watkins-Bruner, Racial
Differences in CYP3A4 Genotype and Survival Among Men Treated
on Radiation Therapy Oncology Group (RTOG) 9202: A Phase
III Randomized Trial. Int J Radiat Oncol Biol Phys, 2007. |
|
Roach, M., 3rd and A. Izaguirre, Goserelin
acetate in combination with radiotherapy for prostate cancer.
Expert Opin Pharmacother, 2007. 8(2): p. 257-64. |
|
Roach, M., 3rd, V. Weinberg, H. Sandler,
and I. Thompson, Staging for prostate cancer: time to incorporate
pretreatment prostate-specific antigen and Gleason score?
Cancer, 2007. 109(2): p. 213-20. |
|
Sahgal, A. and M. Roach, 3rd, Permanent
prostate seed brachytherapy: a current perspective on the
evolution of the technique and its application. Nat Clin
Pract Urol, 2007. 4(12): p. 658-70. |
|
Schiffner, D.C., A.R. Gottschalk, M. Lometti,
M. Aubin, J. Pouliot, J. Speight, I.C. Hsu, K. Shinohara,
and M. Roach, 3rd, Daily electronic portal imaging of implanted
gold seed fiducials in patients undergoing radiotherapy after
radical prostatectomy. Int J Radiat Oncol Biol Phys, 2007.
67(2): p. 610-9. |
|
Speight, J.L. and M. Roach, 3rd, Advances
in the treatment of localized prostate cancer: the role of
anatomic and functional imaging in men managed with radiotherapy.
J Clin Oncol, 2007. 25(8): p. 987-95. |
|
Speight, J.L. and M. Roach, Radiotherapy of Urologic
Tumors, in Smith’s General Urology, J. McAnnich and E. Tanagho,
Editors. 2007, Lange Medical Books/McGraw-Hill. |
|
Stone, N.N., L. Potters, B.J. Davis, J.P. Ciezki, M.J.
Zelefsky, M. Roach, P.A. Fearn, M.W. Kattan, and R.G. Stock,
Customized dose prescription for permanent prostate brachytherapy:
insights from a multicenter analysis of dosimetry outcomes.
Int J Radiat Oncol Biol Phys, 2007. 69(5): p. 1472-7. |
|
Zapotoczna, A., G. Sasso, J. Simpson, and M. Roach, 3rd,
Current role and future perspectives of magnetic resonance
spectroscopy in radiation oncology for prostate cancer. Neoplasia,
2007. 9(6): p. 455-63. |
| |
Publications – 2006 |
|
Abdel-Wahab, M., B.A. Berkey, A. Krishan,
T. O'Brien, E. Hammond, M. Roach, 3rd, C. Lawton, M. Pilepich,
A. Markoe, and A. Pollack, Influence of number of CAG repeats
on local control in the RTOG 86-10 protocol. Am J Clin Oncol,
2006. 29(1): p. 14-20. |
|
Aubin, M., O. Morin, J. Chen, A. Gillis,
B. Pickett, J.F. Aubry, C. Akazawa, J. Speight, M. Roach,
3rd, and J. Pouliot, The use of megavoltage cone-beam CT
to complement CT for target definition in pelvic radiotherapy
in the presence of hip replacement. Br J Radiol, 2006. 79(947):
p. 918-21. |
|
Chan, L.W. and M. Roach, 3rd, Role of radiation
therapy in the treatment of unfavorable risk prostate cancer.
Minerva Urol Nefrol, 2006. 58(4): p. 321-7. |
|
Lee, B. and J. Speight, Bladder Cancer,
in Handbook of Radiation Oncology, E.K. Hansen and M.
Roach, 3rd Editors. 2006, Springer: New York. |
|
Lee, B. and J. Speight, Mesothelioma and Thymoma, in Handbook of Radiation Oncology, E.K. Hansen and M. Roach, 3rd Editors. 2006, Springer: New York. |
|
Lessard, E., S.L. Kwa, B. Pickett, M. Roach,
3rd, and J. Pouliot, Class solution for inversely planned
permanent prostate implants to mimic an experienced dosimetrist.
Med Phys, 2006. 33(8): p. 2773-82. |
|
Morin, O., A. Gillis, J. Chen, M. Aubin,
M.K. Bucci, M. Roach, 3rd, and J. Pouliot, Megavoltage cone-beam
CT: system description and clinical applications. Med Dosim,
2006. 31(1): p. 51-61. |
|
Pickett, B., J. Kurhanewicz, J. Pouliot,
V. Weinberg, K. Shinohara, F. Coakley, and M.
Roach, 3rd,
Three-dimensional conformal external beam radiotherapy compared
with permanent prostate implantation in low-risk prostate
cancer based on endorectal magnetic resonance spectroscopy
imaging and prostate-specific antigen level. Int J Radiat
Oncol Biol Phys, 2006. 65(1): p. 65-72. |
|
Pouliot, J., O. Morin, M. Aubin, J.F. Aubry,
J. Chen, J. Speight, and M. Roach, 3rd, [Megavoltage cone-beam
CT: Recent developments and clinical applications]. Cancer
Radiother, 2006. 10(5): p. 258-68. |
|
Roach, M., 3rd, In reply to Dr. Cheung.
Int J Radiat Oncol Biol Phys, 2006. 66(4): p. 1274-5. |
|
Roach, M., 3rd, M. DeSilvio, R. Valicenti,
D. Grignon, S.O. Asbell, C. Lawton, C.R. Thomas, Jr., and
W.U. Shipley, Whole-pelvis, "mini-pelvis," or prostate-only
external beam radiotherapy after neoadjuvant and concurrent
hormonal therapy in patients treated in the Radiation Therapy
Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys,
2006. 66(3): p. 647-53. |
|
Roach, M., 3rd, G. Hanks, H. Thames, Jr.,
P. Schellhammer, W.U. Shipley, G.H. Sokol, and H. Sandler,
Defining biochemical failure following radiotherapy with
or without hormonal therapy in men with clinically localized
prostate cancer: recommendations of the RTOG-ASTRO Phoenix
Consensus Conference. Int J Radiat Oncol Biol Phys, 2006.
65(4): p. 965-74. |
|
Roach, M., 3rd, V. Weinberg, M. Nash, H.M.
Sandler, P.W. McLaughlin, and M.W. Kattan, Defining high
risk prostate cancer with risk groups and nomograms: implications
for designing clinical trials. J Urol, 2006. 176(6 Pt 2):
p. S16-20. |
|
Shipley, W.U., M. Desilvio, M.V. Pilepich,
M. Roach, 3rd, H.B. Wolkov, W.T. Sause, P. Rubin, and C.A.
Lawton, Early initiation of salvage hormone therapy influences
survival in patients who failed initial radiation for locally
advanced prostate cancer: A secondary analysis of RTOG protocol
86-10. Int J Radiat Oncol Biol Phys, 2006. 64(4): p. 1162-7. |
|
Speight, J.L. and M.
Roach, 3rd, Radiotherapy
in the management of common genitourinary malignancies. Hematol
Oncol Clin North Am, 2006. 20(2): p. 321-46. |
|
Speight, J.L. and M. Roach, New techniques
and management options for localized prostate cancer. Rev
Urol, 2006. 8 Suppl 2: p. S22-9. |
|
Wang-Chesebro, A., P. Xia, J. Coleman,
C. Akazawa, and M. Roach, 3rd, Intensity-modulated radiotherapy
improves lymph node coverage and dose to critical structures
compared with three-dimensional conformal radiation therapy
in clinically localized prostate cancer. Int J Radiat Oncol
Biol Phys, 2006. 66(3): p. 654-62. |
|
Willoughby, T.R., P.A. Kupelian, J. Pouliot,
K. Shinohara, M. Aubin, M. Roach, 3rd, L.L. Skrumeda, J.M.
Balter, D.W. Litzenberg, S.W. Hadley, J.T. Wei, and H.M.
Sandler, Target localization and real-time tracking using
the Calypso 4D localization system in patients with localized
prostate cancer. Int J Radiat Oncol Biol Phys, 2006. 65(2):
p. 528-34. |
| |
return
to top
|
|
|
|
|
|
